Biomarkers for Ovarian Cancer

Iuliana Shapira, MD, Dir. Cancer Genetics Program, North Shore-LIJ Cancer Institute; Annette Lee, PhD., Dir. Laboratory of Translational Genetics & Assoc. Investigator, Feinstein Institute for Medical Research. A ground-breaking, first-of-its-kind scientific research study dedicated to improving the survival rates of women diagnosed with ovarian and breast cancers is taking place at North Shore-LIJ. Researchers have identified genetic markers which will allow patients to individualize their own therapy in order to have maximum benefit and minimal side effects.

Get the latest health news

Keep up-to-date on breaking health news with insights from our experts and developments from around the health system.